WASHINGTON (Reuters) – U.S. President Donald Trump on Monday suggested Pfizer Inc could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.
Asked which drugmaker could be approved, Trump told Fox News in an interview: “Pfizer’s doing really well,” adding “Johnson & Johnson … they’ll probably be a little later.” He also cited efforts by Moderna Inc and AstraZeneca Plc.
(Reporting by Susan Heavey)
